JP2022522889A5 - - Google Patents
Info
- Publication number
- JP2022522889A5 JP2022522889A5 JP2021552586A JP2021552586A JP2022522889A5 JP 2022522889 A5 JP2022522889 A5 JP 2022522889A5 JP 2021552586 A JP2021552586 A JP 2021552586A JP 2021552586 A JP2021552586 A JP 2021552586A JP 2022522889 A5 JP2022522889 A5 JP 2022522889A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025003299A JP2025063135A (ja) | 2019-03-05 | 2025-01-09 | Ａｌアミロイドーシスを処置する方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962814252P | 2019-03-05 | 2019-03-05 | |
| US62/814,252 | 2019-03-05 | ||
| US201962942722P | 2019-12-02 | 2019-12-02 | |
| US62/942,722 | 2019-12-02 | ||
| PCT/IB2020/000186 WO2020178638A1 (en) | 2019-03-05 | 2020-03-05 | Methods of treating al amyloidosis |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025003299A Division JP2025063135A (ja) | 2019-03-05 | 2025-01-09 | Ａｌアミロイドーシスを処置する方法 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022522889A JP2022522889A (ja) | 2022-04-20 |
| JPWO2020178638A5 JPWO2020178638A5 (https=) | 2023-03-13 |
| JP2022522889A5 true JP2022522889A5 (https=) | 2023-03-13 |
| JP7619953B2 JP7619953B2 (ja) | 2025-01-22 |
Family
ID=70476256
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021552586A Active JP7619953B2 (ja) | 2019-03-05 | 2020-03-05 | Ａｌアミロイドーシスを処置する方法 |
| JP2025003299A Pending JP2025063135A (ja) | 2019-03-05 | 2025-01-09 | Ａｌアミロイドーシスを処置する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025003299A Pending JP2025063135A (ja) | 2019-03-05 | 2025-01-09 | Ａｌアミロイドーシスを処置する方法 |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US11692024B2 (https=) |
| EP (2) | EP3934689B1 (https=) |
| JP (2) | JP7619953B2 (https=) |
| KR (1) | KR20220019656A (https=) |
| CN (1) | CN113811332A (https=) |
| AU (1) | AU2020231081A1 (https=) |
| BR (1) | BR112021017550A2 (https=) |
| CA (1) | CA3132780A1 (https=) |
| CL (1) | CL2021002318A1 (https=) |
| FR (1) | FR3111560B1 (https=) |
| IL (1) | IL286040A (https=) |
| JO (1) | JOP20210245A1 (https=) |
| MA (1) | MA55209A (https=) |
| MX (1) | MX2021010665A (https=) |
| PH (1) | PH12021552135A1 (https=) |
| SG (1) | SG11202109645QA (https=) |
| WO (1) | WO2020178638A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH12021552135A1 (en) * | 2019-03-05 | 2022-08-31 | Prothena Biosciences Ltd | Methods of treating al amyloidosis |
| AU2021339851A1 (en) * | 2020-09-14 | 2023-04-13 | Caelum Biosciences, Inc. | Method of treating amyloidosis |
| TW202332465A (zh) * | 2021-01-29 | 2023-08-16 | 愛爾蘭商普羅希那生物科學有限公司 | 治療al類澱粉變性症之方法 |
| US20250345418A1 (en) * | 2022-01-11 | 2025-11-13 | Prothena Biosciences Limited | Methods of treating al amyloidosis |
| AR132344A1 (es) * | 2023-04-10 | 2025-06-18 | Medimmune Llc | Optimización de los dominios de unión al antígeno cd3 |
| TW202547553A (zh) * | 2024-02-06 | 2025-12-16 | 愛爾蘭商普羅希那生物科學有限公司 | 治療ａｌ類澱粉變性症之方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030147882A1 (en) | 1998-05-21 | 2003-08-07 | Alan Solomon | Methods for amyloid removal using anti-amyloid antibodies |
| PT1355919E (pt) | 2000-12-12 | 2011-03-02 | Medimmune Llc | Moléculas com semivida longa, composições que as contêm e suas utilizações |
| US8263746B2 (en) | 2004-02-06 | 2012-09-11 | Morphosys Ag | Anti-CD38 human antibodies and uses thereof |
| EP2567976B1 (en) | 2005-03-23 | 2017-07-19 | Genmab A/S | Antibodies against CD38 for treatment of multiple myeloma |
| DK2237803T3 (en) | 2007-12-28 | 2015-10-05 | Prothena Biosciences Ltd | Treatment and prophylaxis of amyloidosis |
| DK2580243T3 (da) | 2010-06-09 | 2020-01-13 | Genmab As | Antibodies against human cd38 |
| SG10201604104PA (en) | 2011-10-25 | 2016-07-28 | Prothena Therapeutics Ltd | Antibody formulations and methods |
| AU2012328524B2 (en) | 2011-10-28 | 2017-05-18 | Excelse Bio, Inc. | Protein formulations containing amino acids |
| US10213506B2 (en) | 2014-08-26 | 2019-02-26 | University Of Tennessee Research Foundation | Targeting immunotherapy for amyloidosis |
| MX389805B (es) | 2015-05-20 | 2025-03-11 | Janssen Biotech Inc | Anticuerpos anti-cd38 para el tratamiento de amiloidosis de cadena ligera y otras enfermedades malignas hematológicas positivas para cd38. |
| DK3827845T3 (da) | 2015-11-03 | 2022-05-23 | Janssen Biotech Inc | Subkutane formuleringer af anti-cd38-antistoffer og anvendelser deraf |
| WO2018005967A1 (en) | 2016-06-30 | 2018-01-04 | Prothena Therapeutics Limited | Compositions for treating amyloidosis |
| US11382974B2 (en) * | 2017-08-01 | 2022-07-12 | The Trustees Of Columbia University In The City Of New York | Methods and compositions for treatment of amyloid deposition diseases |
| US12018069B2 (en) | 2018-06-28 | 2024-06-25 | The Trustees Of Columbia University In The City Of New York | Methods and compositions for imaging amyloid deposits |
| AU2019429147B2 (en) | 2019-02-12 | 2024-11-14 | Prothena Biosciences Limited | Treatment of AL amyloidosis with the combination of monoclonal antibodies against immunoglobulin light chains and the CD38 cell membrane molecule on antibody-producing and other immune cells |
| PH12021552135A1 (en) * | 2019-03-05 | 2022-08-31 | Prothena Biosciences Ltd | Methods of treating al amyloidosis |
| TW202332465A (zh) | 2021-01-29 | 2023-08-16 | 愛爾蘭商普羅希那生物科學有限公司 | 治療al類澱粉變性症之方法 |
-
2020
- 2020-03-05 PH PH1/2021/552135A patent/PH12021552135A1/en unknown
- 2020-03-05 BR BR112021017550A patent/BR112021017550A2/pt unknown
- 2020-03-05 SG SG11202109645Q patent/SG11202109645QA/en unknown
- 2020-03-05 US US16/810,319 patent/US11692024B2/en active Active
- 2020-03-05 WO PCT/IB2020/000186 patent/WO2020178638A1/en not_active Ceased
- 2020-03-05 JP JP2021552586A patent/JP7619953B2/ja active Active
- 2020-03-05 EP EP20722638.2A patent/EP3934689B1/en active Active
- 2020-03-05 CN CN202080033593.5A patent/CN113811332A/zh active Pending
- 2020-03-05 AU AU2020231081A patent/AU2020231081A1/en active Pending
- 2020-03-05 CA CA3132780A patent/CA3132780A1/en active Pending
- 2020-03-05 EP EP25163966.2A patent/EP4582446A3/en active Pending
- 2020-03-05 MX MX2021010665A patent/MX2021010665A/es unknown
- 2020-03-05 KR KR1020217031814A patent/KR20220019656A/ko active Pending
- 2020-03-05 MA MA055209A patent/MA55209A/fr unknown
-
2021
- 2021-06-16 FR FR2106376A patent/FR3111560B1/fr active Active
- 2021-09-01 IL IL286040A patent/IL286040A/en unknown
- 2021-09-03 CL CL2021002318A patent/CL2021002318A1/es unknown
- 2021-09-05 JO JOP/2021/0245A patent/JOP20210245A1/ar unknown
-
2023
- 2023-05-08 US US18/313,792 patent/US12240894B2/en active Active
-
2025
- 2025-01-09 JP JP2025003299A patent/JP2025063135A/ja active Pending
- 2025-03-03 US US19/068,630 patent/US20250188159A1/en active Pending